Literature DB >> 29558876

Performance Improvement to Decrease Readmission Rates for Patients With a Left Ventricular Assist Device.

Jackeline Iseler1, John Fox2, Kelly Wierenga3.   

Abstract

BACKGROUND: The 30-day readmission rate for patients with a left ventricular assist device implantation at a large, urban, Midwest hospital system (from October 2013 to September 2014) was estimated at 32.1%. PROBLEM STATEMENT: Readmission rates were a concern at this facility. Review of the readmissions, change in practice, and home expectations of patients and families have identified an opportunity to improve the transitions of care for this left ventricular assist device (LVAD) program. Therefore, the purpose of this project was to evaluate the effectiveness and feasibility of a transitional care model (TCM) for care of patients with left ventricular devices.
METHODS: Ten patients were enrolled in the pilot that was implemented in June 2015. A transitional care nurse trained to support patients with ventricular assist devices was used to facilitate patient flow. The goal was to create an individualized plan for the development or improvement of self-management skills to decrease readmission rates. The transitional care nurse collaborated with the ventricular device team. OUTCOMES: The 30-day readmission rate during the pilot was 14.3% compared to the previous annual overall rate of 42.6%. IMPLICATIONS FOR PRACTICE: Based on these results, further research is recommended into interventions consistent with the TCM to advance care coordination and to facilitate care transition in the this fragile patient population.

Entities:  

Keywords:  advanced practice nurses; evaluation and quality improvement program; heart assist devices; readmission; transitional programs

Mesh:

Year:  2018        PMID: 29558876      PMCID: PMC5999042          DOI: 10.1177/1526924818765820

Source DB:  PubMed          Journal:  Prog Transplant        ISSN: 1526-9248            Impact factor:   1.187


  38 in total

1.  Translating research into practice: transitional care for older adults.

Authors:  Mary D Naylor; Penny Hollander Feldman; Stacen Keating; Mary Jane Koren; Ellen T Kurtzman; Maureen C Maccoy; Randall Krakauer
Journal:  J Eval Clin Pract       Date:  2009-12       Impact factor: 2.431

Review 2.  Nonadherence in the Advanced Heart Failure Population.

Authors:  Jonathan Gandhi; Andrew McCue; Robert Cole
Journal:  Curr Heart Fail Rep       Date:  2016-04

3.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher; Jeroen J Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A Popescu; Zeljko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; Theresa McDonagh; Udo Sechtem; Luis Almenar Bonet; Panayiotis Avraamides; Hisham A Ben Lamin; Michele Brignole; Antonio Coca; Peter Cowburn; Henry Dargie; Perry Elliott; Frank Arnold Flachskampf; Guido Francesco Guida; Suzanna Hardman; Bernard Iung; Bela Merkely; Christian Mueller; John N Nanas; Olav Wendelboe Nielsen; Stein Orn; John T Parissis; Piotr Ponikowski
Journal:  Eur J Heart Fail       Date:  2012-08       Impact factor: 15.534

4.  Effectiveness and cost of a transitional care program for heart failure: a prospective study with concurrent controls.

Authors:  Brett D Stauffer; Cliff Fullerton; Neil Fleming; Gerald Ogola; Jeph Herrin; Pamala Martin Stafford; David J Ballard
Journal:  Arch Intern Med       Date:  2011-07-25

Review 5.  The care span: The importance of transitional care in achieving health reform.

Authors:  Mary D Naylor; Linda H Aiken; Ellen T Kurtzman; Danielle M Olds; Karen B Hirschman
Journal:  Health Aff (Millwood)       Date:  2011-04       Impact factor: 6.301

6.  Transitional care of older adults hospitalized with heart failure: a randomized, controlled trial.

Authors:  Mary D Naylor; Dorothy A Brooten; Roberta L Campbell; Greg Maislin; Kathleen M McCauley; J Sanford Schwartz
Journal:  J Am Geriatr Soc       Date:  2004-05       Impact factor: 5.562

7.  Comprehensive discharge planning for the hospitalized elderly. A randomized clinical trial.

Authors:  M Naylor; D Brooten; R Jones; R Lavizzo-Mourey; M Mezey; M Pauly
Journal:  Ann Intern Med       Date:  1994-06-15       Impact factor: 25.391

8.  Performance Improvement to Decrease Readmission Rates for Patients With a Left Ventricular Assist Device.

Authors:  Jackeline Iseler; John Fox; Kelly Wierenga
Journal:  Prog Transplant       Date:  2018-03-20       Impact factor: 1.187

9.  APN-directed transitional home care model: achieving positive outcomes for patients with COPD.

Authors:  Donna Felber Neff; Elizabeth Madigan; Georgia Narsavage
Journal:  Home Healthc Nurse       Date:  2003-08

Review 10.  The Experience of Family Caregivers of Patients With a Left Ventricular Assist Device: An Integrative Review.

Authors:  Giancarlo Cicolini; Francesca Cerratti; Carlo Della Pelle; Valentina Simonetti
Journal:  Prog Transplant       Date:  2016-04-04       Impact factor: 1.187

View more
  1 in total

1.  Performance Improvement to Decrease Readmission Rates for Patients With a Left Ventricular Assist Device.

Authors:  Jackeline Iseler; John Fox; Kelly Wierenga
Journal:  Prog Transplant       Date:  2018-03-20       Impact factor: 1.187

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.